evaluate the pharmaceuticals company saxenda on glp-1 drugs for diabetes Saxenda® Liraglutide Weight Loss Program Saxenda (liraglutide): Uses, Side Effects,
Description
Collaborative Network database of adults aged 18 years and older with type 2 diabetes who were prescribed tirzepatide (Mounjaro, Eli Lilly) or a GLP-1 receptor agonist from June 1, 2022, to June 20, 2023
[DOI] [PubMed] [Google Scholar] 496.Cheng X., Ji Z., Tsalkova T., Mei F
By Drug By Route of Administration By Distribution Channel By Dosage Strength By End User By Therapy Line By Patient Age Group By BMI Category By Region Table 1: U.S
They are also administered at different doses and last for different durations
